Gamma Medica: Healthcare Technology Campaign
Gamma Medica is part of a massive healthcare technological effort to find new ways to diagnose and treat cancers. In 2015, the Mayo Clinic published a study in the American Journal of Roentgenology that featured Gamma Medica’s LumaGEM, a breast imaging system that yields superior images with low radiation exposure.
This important feature of Gamma Medica’s healthcare technology deserved national recognition. Racepoint Global launched a healthcare technology campaign promoting the study in national conversations on breast cancer, highlighting the fact that this technology and those like it quadruple detection of invasive breast cancers in women. RPG leveraged the prestigious Mayo Clinic name to generate additional creativity and buzz and inserted the study into conversations about women regularly seeing their physicians to talk about breast cancer.
RPG secured media coverage in WSJ, Axis Imaging News, Cancer Connect and Breast Cancer News with significant interest from reporters at Reuters, AARP and Forbes.